Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | March 22, 2024 09:06am

Gainers

  • Biolase (NASDAQ:BIOL) shares moved upwards by 61.5% to $0.24 during Friday's pre-market session. The market value of their outstanding shares is at $4.6 million. The company's, Q4 earnings came out yesterday.
  • Outlook Therapeutics (NASDAQ:OTLK) shares moved upwards by 46.73% to $10.33. The market value of their outstanding shares is at $222.9 million.
  • Eton Pharmaceuticals (NASDAQ:ETON) shares rose 15.46% to $4.18. The market value of their outstanding shares is at $107.3 million.
  • Monogram Orthopaedics (NASDAQ:MGRM) stock moved upwards by 13.15% to $2.58. The market value of their outstanding shares is at $81.6 million.
  • Ontrak (NASDAQ:OTRK) shares increased by 11.49% to $0.29. The company's market cap stands at $7.9 million.
  • Nutriband (NASDAQ:NTRB) shares moved upwards by 10.16% to $2.71. The company's market cap stands at $22.9 million.

Losers

  • SINTX Techs (NASDAQ:SINT) shares declined by 34.0% to $0.09 during Friday's pre-market session.
  • Cutera (NASDAQ:CUTR) shares fell 10.87% to $2.05. The company's market cap stands at $40.9 million. As per the press release, Q4 earnings came out yesterday.
  • Telesis Bio (NASDAQ:TBIO) stock decreased by 9.82% to $0.42. The market value of their outstanding shares is at $12.5 million.
  • Grifols (NASDAQ:GRFS) stock declined by 9.65% to $6.13. The market value of their outstanding shares is at $4.1 billion.
  • Yield10 Bioscience (NASDAQ:YTEN) stock fell 9.37% to $0.39. The market value of their outstanding shares is at $4.7 million.
  • Nkarta (NASDAQ:NKTX) shares decreased by 9.1% to $11.8. The company's market cap stands at $579.0 million. The company's, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BIOL CUTR ETON GRFS MGRM NKTX NTRB OTLK OTRK SINT TBIO YTEN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist